Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Accounts Payables (2016 - 2025)

Bio Key International's Accounts Payables history spans 16 years, with the latest figure at $655647.0 for Q3 2025.

  • For Q3 2025, Accounts Payables fell 58.1% year-over-year to $655647.0; the TTM value through Sep 2025 reached $655647.0, down 58.1%, while the annual FY2024 figure was $818187.0, 37.83% down from the prior year.
  • Accounts Payables for Q3 2025 was $655647.0 at Bio Key International, down from $889026.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.9 million in Q2 2023 and bottomed at $309323.0 in Q1 2021.
  • The 5-year median for Accounts Payables is $1.1 million (2022), against an average of $1.1 million.
  • The largest annual shift saw Accounts Payables skyrocketed 356.86% in 2021 before it tumbled 58.1% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $427772.0 in 2021, then soared by 159.08% to $1.1 million in 2022, then grew by 18.74% to $1.3 million in 2023, then tumbled by 37.83% to $818187.0 in 2024, then decreased by 19.87% to $655647.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Accounts Payables are $655647.0 (Q3 2025), $889026.0 (Q2 2025), and $568836.0 (Q1 2025).